Featured Research

from universities, journals, and other organizations

Vision-Saving Treatment Effective For Patients With Eye Cancer

Date:
July 16, 2001
Source:
Ohio State University
Summary:
Patients suffering from a certain form of cancer of the eye may not need to have their diseased eye removed, based on a new study. The results of the Collaborative Ocular Melanoma Study (COMS), a multi-center trial released today by the Archives of Ophthalmology, found that survival rates were the same regardless of whether the eye was removed or the patient had instead undergone radiation therapy.

COLUMBUS, Ohio - Patients suffering from a certain form of cancer of the eye may not need to have their diseased eye removed, based on a new study.

The results of the Collaborative Ocular Melanoma Study (COMS), a multi-center trial released today by the Archives of Ophthalmology, found that survival rates were the same regardless of whether the eye was removed or the patient had instead undergone radiation therapy. Ohio State University is one of more than 40 centers throughout the United States and Canada participating in the study.

Traditionally, physicians have removed the affected eye in patients with this disease, said Frederick Davidorf, a professor of ophthalmology at Ohio State and a principal investigator with the COMS.

The study looked at 1,317 patients with choroidal melanoma -- or cancer of the choroid, the thin layer of vessels beneath the retina. The choroid contains most of the eye's melanocytes, cells that produce and contain pigment. The patients all had medium-sized tumors (2.5 to 10 mm in height and no more than 16 mm in diameter) - ranging from the size of a small pea to a lima bean. Removal of the eye is still the only option for patients with larger tumors, Davidorf said.

Half of the patients (657) underwent radiation therapy, while the other half (660) had their affected eye removed. Findings show that 82 percent of the former group and 81 percent of the latter group were living five years after initial treatment. Also, there was no evidence that either treatment caused harm to the unaffected eye, Davidorf said.

"This is a better-than-expected survival rate, based on information from previous studies of fewer patients," Davidorf said. "We had only expected a 70 percent five-year survival rate when we began the study 16 years ago."

Of the patients who underwent radiation therapy, 63 percent had visual acuity of 20/200 or worse in the treated eye. By five years after treatment, 12 percent had had the treated eye removed due to complications of the radiation treatment or tumor growth. The Ohio State researchers will continue to follow each patient for at least 15 years from initial treatment.

According to the National Eye Institute, between 1,600 and 2,400 new cases of ocular melanoma are diagnosed each year in the United States and Canada.

For more than a century, removal of the eye was the standard treatment for choroidal melanoma, regardless of tumor size.

"The results of this study will save many future patients the physical and mental trauma associated with the loss of an eye," Davidorf said.

Ohio State researchers began looking at radiation as an alternate therapy for choroidal melanoma as early as the late 1960s. A study co-authored by Davidorf in the January 1970 Archives of Ophthalmology found that four out of five patients with choroidal melanoma were successfully treated with radiation.

Eye care professionals typically detect melanoma by dilating a patient's pupil.

The COMS was funded by the National Eye Institute and the National Cancer Institute, which are both part of the National Institutes of Health.


Story Source:

The above story is based on materials provided by Ohio State University. Note: Materials may be edited for content and length.


Cite This Page:

Ohio State University. "Vision-Saving Treatment Effective For Patients With Eye Cancer." ScienceDaily. ScienceDaily, 16 July 2001. <www.sciencedaily.com/releases/2001/07/010716113112.htm>.
Ohio State University. (2001, July 16). Vision-Saving Treatment Effective For Patients With Eye Cancer. ScienceDaily. Retrieved September 21, 2014 from www.sciencedaily.com/releases/2001/07/010716113112.htm
Ohio State University. "Vision-Saving Treatment Effective For Patients With Eye Cancer." ScienceDaily. www.sciencedaily.com/releases/2001/07/010716113112.htm (accessed September 21, 2014).

Share This



More Health & Medicine News

Sunday, September 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Sierra Leone's Nationwide Ebola Curfew Underway

Sierra Leone's Nationwide Ebola Curfew Underway

Newsy (Sep. 20, 2014) Sierra Leone is locked down as aid workers and volunteers look for new cases of Ebola. Video provided by Newsy
Powered by NewsLook.com
Changes Found In Brain After One Dose Of Antidepressants

Changes Found In Brain After One Dose Of Antidepressants

Newsy (Sep. 19, 2014) A study suggest antidepressants can kick in much sooner than previously thought. Video provided by Newsy
Powered by NewsLook.com
Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins